InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by RALLIS CHRIS A, Director. Officer active across 1 companies, notably Fennec Pharmaceuticals INC.. In total, 3 reports have been published. The latest transaction was disclosed on 8 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
€4,6028,333 shares@ €0.55220.0017% mcap34.9% of flow
Common Shares
SEC:0001104659-22-031286:0·
€4,3013,333 shares@ €1.2903100.0% of flow
Common Shares
SEC:0001104659-21-128430·
€4,3013,333 shares@ €1.29030.0016% mcap32.6% of flow
Common Shares
SEC:0001104659-21-128430:0·
3 of 3 declarations
About RALLIS CHRIS A
Chris A. Rallis is a Board Member of Fennec Pharmaceuticals Inc., where he contributes to the governance and strategy of the company. His experience in the pharmaceutical sector is valuable to the board, allowing him to make informed decisions.
